Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

EyePoint Pharmaceuticals Inc. buy Zati

Start price
€14.00
12.01.26 / 50%
Target price
-
12.02.26
Performance (%)
-1.64%
Price
€13.00
13.01.26
Summary
This prediction is currently active. With a performance of -1.64%, the BUY prediction for EyePoint Pharmaceuticals Inc. by Zati is down slightly. This prediction currently runs until 12.02.26. The prediction end date can be changed by Zati at any time. Zati has 50% into this prediction
Performance without dividends (%)
Name 1w
EyePoint Pharmaceuticals Inc. -1.64%
iShares Core DAX® 1.644%
iShares Nasdaq 100 0.747%
iShares Nikkei 225® 2.442%
iShares S&P 500 0.618%

Comments by Zati for this prediction